We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Starlims Technologies Ltd. (MM) | NASDAQ:LIMS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.97 | 0 | 01:00:00 |
STARLIMS Technologies
Ltd.
(Name of Registrant)
32B Habarzel Street,
Tel Aviv 69710, Israel
(Address of Principal
Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- __________
STARLIMS Technologies Ltd.
6-K Items
1. | Press release: Public Health Agency in Major US Metropolis Expands STARLIMS License to Cover Clinical Testing, H1N1 Response; dated August 27, 2009 |
ITEM 1
HOLLYWOOD, Fla., August 27, 2009 STARLIMS Technologies Ltd. (Nasdaq:LIMS), a leading provider of laboratory information management systems, or LIMS, today announced an expansion to its original contract with the public health agency of a major U.S. city. The new agreement provides an enterprise license for all of the agencys divisions, extending STARLIMS to the citys health providers to streamline specimen registration, tracking and reporting. The expanded licensing agreement increases the total contract value to approximately $1.3 million, including licenses for the Companys software, first year maintenance and professional services.
The original agreement of May 2009 provided STARLIMS licensing for two of the agencys four public health divisions, while the extended agreement covers all four divisions, including accelerated deployment in the divisions of Microbiology and of Virology and Immunology. The agencys laboratories are responsible for testing more than 400,000 specimens annually. One of the drivers for this expansion was STARLIMSs proven success helping public health agencies to meet the unique challenges of H1N1 influenza.
We are extremely gratified to see that the public health informatics expertise we have developed over years of collaboration with federal, state and local agencies will be fully utilized in this major metropolitan area, said Jeff Ferguson, COO of STARLIMS. Over the past months, we have collaborated in an intensely focused fashion with various public health agencies to help our partners respond rapidly and effectively to the H1N1 influenza virus. The tools we have developed will now be available across the public health divisions of this large metropolis, thanks to the expansion of our licensing agreement.
STARLIMS and H1N1 Testing
STARLIMS has proven success
collaborating with public health partners in H1N1 response, partnering closely with
agencies such as the Louisiana Office of Public Health, the Wyoming Department of Health,
the Tennessee Department of Health and the San Diego County Public Health Department. In a
related initiative, STARLIMS is helping develop a standard influenza testing module, as a
major component of the Laboratory Response Network for Bioterrorism (LRNB) of the United
States Centers for Disease Control and Prevention (CDC). This collaboration involves not
only the CDC and STARLIMS, but also state public health agencies in Indiana, California
and Illinois.
STARLIMS Solutions for
Public Health Informatics
STARLIMS public health solutions
provide the infrastructure for timely sharing of laboratory information among state and
federal public health agencies which is crucial for effective response to emerging
public health threats, including outbreaks of infectious diseases. STARLIMS fully supports
the guidelines set forth by the CDC and the United States Association of Public Health
Laboratories (APHL).
STARLIMSs enterprise-level information system brings together all public health laboratory activities into a single platform, offering comprehensive reporting, surveillance and networking capabilities. Advanced web-based capabilities are enhanced by specialized tools and wizards, resulting in flexible solutions that enable public health labs to manage large amounts of data while also meeting stringent accreditation requirements.
About STARLIMS
STARLIMS Technologies Ltd.
(Nasdaq:LIMS) is a leading provider of laboratory information management systems (LIMS),
with over 20 years of LIMS experience. The Companys flagship product, STARLIMS®,
improves the reliability of laboratory sampling processes, supports compliance with
domestic and international regulations and industry standards, and provides comprehensive
reporting, monitoring and analysis capabilities. STARLIMS software is used for quality
assurance and control, testing and monitoring, and research and development in government,
manufacturing and life sciences organizations. With operations in the United States,
Canada, the United Kingdom, Israel and Hong Kong, the company serves over 500
organizations in 40 countries. For more information, please see http://www.starlims.com.
Safe Harbor for
Forward-Looking Statements
This press release contains
forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties
which could cause the actual results, performance or achievements of the company to be
materially different from those which may be expressed or implied by such statements,
including, among others, changes in general economic and business conditions, changes in
demand for products and services, the timing and amount or cancellation of orders, loss of
market share and other risks detailed from time to time in STARLIMSs filings from
time to time with the Securities and Exchange Commission. Such filings contain and
identify these and other important factors that could cause actual results to differ
materially from those contained in our projections or forward-looking statements.
Shareholders and other readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date on which they are made. We
undertake no obligation to update publicly or revise any forward-looking statement.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
STARLIMS Technologies Ltd.
(Registrant) By: /s/ Chaim Friedman Chaim Friedman Chief Financial Officer |
Date: August 27, 2009
1 Year Starlims Technologies Ltd. (MM) Chart |
1 Month Starlims Technologies Ltd. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions